A citation-based method for searching scientific literature

Amy C Sturm, Joshua W Knowles, Samuel S Gidding, Zahid S Ahmad, Catherine D Ahmed, Christie M Ballantyne, Seth J Baum, Mafalda Bourbon, Alain Carrié, Marina Cuchel, Sarah D de Ferranti, Joep C Defesche, Tomas Freiberger, Ray E Hershberger, G Kees Hovingh, Lala Karayan, Johannes Jacob Pieter Kastelein, Iris Kindt, Stacey R Lane, Sarah E Leigh, MacRae F Linton, Pedro Mata, William A Neal, Børge G Nordestgaard, Raul D Santos, Mariko Harada-Shiba, Eric J Sijbrands, Nathan O Stitziel, Shizuya Yamashita, Katherine A Wilemon, David H Ledbetter, Daniel J Rader. J Am Coll Cardiol 2018
Times Cited: 196







List of co-cited articles
680 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Børge G Nordestgaard, M John Chapman, Steve E Humphries, Henry N Ginsberg, Luis Masana, Olivier S Descamps, Olov Wiklund, Robert A Hegele, Frederick J Raal, Joep C Defesche,[...]. Eur Heart J 2013
60

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.
Amit V Khera, Hong-Hee Won, Gina M Peloso, Kim S Lawson, Traci M Bartz, Xuan Deng, Elisabeth M van Leeuwen, Pradeep Natarajan, Connor A Emdin, Alexander G Bick,[...]. J Am Coll Cardiol 2016
458
37

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
Ilse K Luirink, Albert Wiegman, D Meeike Kusters, Michel H Hof, Jaap W Groothoff, Eric de Groot, John J P Kastelein, Barbara A Hutten. N Engl J Med 2019
174
34

The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.
Samuel S Gidding, Mary Ann Champagne, Sarah D de Ferranti, Joep Defesche, Matthew K Ito, Joshua W Knowles, Brian McCrindle, Frederick Raal, Daniel Rader, Raul D Santos,[...]. Circulation 2015
360
28

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
27

Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Pengwei Hu, Kanika I Dharmayat, Christophe A T Stevens, Mansour T A Sharabiani, Rebecca S Jones, Gerald F Watts, Jacques Genest, Kausik K Ray, Antonio J Vallejo-Vaz. Circulation 2020
110
25

Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
Sabina O Beheshti, Christian M Madsen, Anette Varbo, Børge G Nordestgaard. J Am Coll Cardiol 2020
109
24

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
Albert Wiegman, Samuel S Gidding, Gerald F Watts, M John Chapman, Henry N Ginsberg, Marina Cuchel, Leiv Ose, Maurizio Averna, Catherine Boileau, Jan Borén,[...]. Eur Heart J 2015
388
21

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.
Marina Cuchel, Eric Bruckert, Henry N Ginsberg, Frederick J Raal, Raul D Santos, Robert A Hegele, Jan Albert Kuivenhoven, Børge G Nordestgaard, Olivier S Descamps, Elisabeth Steinhagen-Thiessen,[...]. Eur Heart J 2014
585
20

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
20

Genetic identification of familial hypercholesterolemia within a single U.S. health care system.
Noura S Abul-Husn, Kandamurugu Manickam, Laney K Jones, Eric A Wright, Dustin N Hartzel, Claudia Gonzaga-Jauregui, Colm O'Dushlaine, Joseph B Leader, H Lester Kirchner, D'Andra M Lindbuchler,[...]. Science 2016
223
19

Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES).
Sarah D de Ferranti, Angie Mae Rodday, Michael M Mendelson, John B Wong, Laurel K Leslie, R Christopher Sheldrick. Circulation 2016
225
19

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.
Katherine A Wilemon, Jasmine Patel, Carlos Aguilar-Salinas, Catherine D Ahmed, Mutaz Alkhnifsawi, Wael Almahmeed, Rodrigo Alonso, Khalid Al-Rasadi, Lina Badimon, Luz M Bernal,[...]. JAMA Cardiol 2020
80
23


Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics.
R R Williams, S C Hunt, M C Schumacher, R A Hegele, M F Leppert, E H Ludwig, P N Hopkins. Am J Cardiol 1993
376
16

Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.
Jian Wang, Jacqueline S Dron, Matthew R Ban, John F Robinson, Adam D McIntyre, Maher Alazzam, Pei Jun Zhao, Allison A Dilliott, Henian Cao, Murray W Huff,[...]. Arterioscler Thromb Vasc Biol 2016
130
16

Familial hypercholesterolaemia.
Joep C Defesche, Samuel S Gidding, Mariko Harada-Shiba, Robert A Hegele, Raul D Santos, Anthony S Wierzbicki. Nat Rev Dis Primers 2017
178
15

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.
Philippa J Talmud, Sonia Shah, Ros Whittall, Marta Futema, Philip Howard, Jackie A Cooper, Seamus C Harrison, Kawah Li, Fotios Drenos, Frederik Karpe,[...]. Lancet 2013
370
15

Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.
Leo E Akioyamen, Jacques Genest, Shubham D Shan, Rachel L Reel, Jordan M Albaum, Anna Chu, Jack V Tu. BMJ Open 2017
160
14

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
Raul D Santos, Samuel S Gidding, Robert A Hegele, Marina A Cuchel, Philip J Barter, Gerald F Watts, Seth J Baum, Alberico L Catapano, M John Chapman, Joep C Defesche,[...]. Lancet Diabetes Endocrinol 2016
214
14


Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
David S Wald, Jonathan P Bestwick, Joan K Morris, Ken Whyte, Lucy Jenkins, Nicholas J Wald. N Engl J Med 2016
166
13

Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.
Hayato Tada, Masa-Aki Kawashiri, Atsushi Nohara, Akihiro Inazu, Hiroshi Mabuchi, Masakazu Yamagishi. Eur Heart J 2017
85
15

Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association.
Emily E Brown, Amy C Sturm, Marina Cuchel, Lynne T Braun, P Barton Duell, James A Underberg, Terry A Jacobson, Robert A Hegele. J Clin Lipidol 2020
29
44

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.
Mariko Harada-Shiba, Hidenori Arai, Yasushi Ishigaki, Shun Ishibashi, Tomonori Okamura, Masatsune Ogura, Kazushige Dobashi, Atsushi Nohara, Hideaki Bujo, Katsumi Miyauchi,[...]. J Atheroscler Thromb 2018
99
12

The complex molecular genetics of familial hypercholesterolaemia.
Amanda J Berberich, Robert A Hegele. Nat Rev Cardiol 2019
101
12

Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
Melissa A Austin, Carolyn M Hutter, Ron L Zimmern, Steve E Humphries. Am J Epidemiol 2004
402
11

Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia.
Frederick J Raal, David Kallend, Kausik K Ray, Traci Turner, Wolfgang Koenig, R Scott Wright, Peter L J Wijngaard, Danielle Curcio, Mark J Jaros, Lawrence A Leiter,[...]. N Engl J Med 2020
158
11

Evinacumab for Homozygous Familial Hypercholesterolemia.
Frederick J Raal, Robert S Rosenson, Laurens F Reeskamp, G Kees Hovingh, John J P Kastelein, Paolo Rubba, Shazia Ali, Poulabi Banerjee, Kuo-Chen Chan, Daniel A Gipe,[...]. N Engl J Med 2020
158
11

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study.
Jorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, Joep C Defesche, Dick C G Basart, Anho H Liem, Jan Heeringa, Jacqueline C Witteman, Peter J Lansberg, John J P Kastelein,[...]. BMJ 2008
488
11

High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study.
Anne Langsted, Pia R Kamstrup, Marianne Benn, Anne Tybjærg-Hansen, Børge G Nordestgaard. Lancet Diabetes Endocrinol 2016
145
11

Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, Cristina Fernández-Pérez, Ovidio Muñiz, José Luis Díaz-Díaz, Adriana Saltijeral, Francisco Fuentes-Jiménez, Raimundo de Andrés, Daniel Zambón,[...]. Circulation 2017
171
11

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
Marianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, Delphine Allard, Khadija Ouguerram, Martine Devillers, Corinne Cruaud, Suzanne Benjannet, Louise Wickham, Danièle Erlich,[...]. Nat Genet 2003
11

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
Emil M deGoma, Zahid S Ahmad, Emily C O'Brien, Iris Kindt, Peter Shrader, Connie B Newman, Yashashwi Pokharel, Seth J Baum, Linda C Hemphill, Lisa C Hudgins,[...]. Circ Cardiovasc Genet 2016
123
10


Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.
Don P Wilson, Terry A Jacobson, Peter H Jones, Marlys L Koschinsky, Catherine J McNeal, Børge G Nordestgaard, Carl E Orringer. J Clin Lipidol 2019
143
10

Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands.
M A Umans-Eckenhausen, J C Defesche, E J Sijbrands, R L Scheerder, J J Kastelein. Lancet 2001
313
10

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.
Frederick J Raal, G Kees Hovingh, Dirk Blom, Raul D Santos, Mariko Harada-Shiba, Eric Bruckert, Patrick Couture, Handrean Soran, Gerald F Watts, Christopher Kurtz,[...]. Lancet Diabetes Endocrinol 2017
137
10

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
Antonio J Vallejo-Vaz, Martina De Marco, Christophe A T Stevens, Asif Akram, Tomas Freiberger, G Kees Hovingh, John J P Kastelein, Pedro Mata, Frederick J Raal, Raul D Santos,[...]. Atherosclerosis 2018
91
10

Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
Mark Trinder, Xuan Li, Maria Liza DeCastro, Luba Cermakova, Singh Sadananda, Linda M Jackson, Hawmid Azizi, G B John Mancini, Gordon A Francis, Jiri Frohlich,[...]. J Am Coll Cardiol 2019
64
15

Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
Joost Besseling, G Kees Hovingh, Roeland Huijgen, John J P Kastelein, Barbara A Hutten. J Am Coll Cardiol 2016
107
9

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Scott M Grundy, Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman,[...]. J Am Coll Cardiol 2019
865
9

Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.
Sarah D de Ferranti, Julia Steinberger, Rebecca Ameduri, Annette Baker, Holly Gooding, Aaron S Kelly, Michele Mietus-Snyder, Mark M Mitsnefes, Amy L Peterson, Julie St-Pierre,[...]. Circulation 2019
95
9

Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease.
Hayato Tada, Masa-Aki Kawashiri, Akihiro Nomura, Ryota Teramoto, Kazuyoshi Hosomichi, Atsushi Nohara, Akihiro Inazu, Hiroshi Mabuchi, Atsushi Tajima, Masakazu Yamagishi. J Clin Lipidol 2018
41
21

Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care.
Gerald F Watts, Samuel S Gidding, Pedro Mata, Jing Pang, David R Sullivan, Shizuya Yamashita, Frederick J Raal, Raul D Santos, Kausik K Ray. Nat Rev Cardiol 2020
38
23

Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.
Marianne Benn, Gerald F Watts, Anne Tybjaerg-Hansen, Børge G Nordestgaard. J Clin Endocrinol Metab 2012
401
8

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Anne C Goldberg, Paul N Hopkins, Peter P Toth, Christie M Ballantyne, Daniel J Rader, Jennifer G Robinson, Stephen R Daniels, Samuel S Gidding, Sarah D de Ferranti, Matthew K Ito,[...]. J Clin Lipidol 2011
311
8

Long-Term Evolocumab in Patients With Familial Hypercholesterolemia.
Raul D Santos, Evan A Stein, G Kees Hovingh, Dirk J Blom, Handrean Soran, Gerald F Watts, J Antonio G López, Sarah Bray, Christopher E Kurtz, Andrew W Hamer,[...]. J Am Coll Cardiol 2020
69
11

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
Raul D Santos, Andrea Ruzza, G Kees Hovingh, Albert Wiegman, François Mach, Christopher E Kurtz, Andrew Hamer, Ian Bridges, Andrea Bartuli, Jean Bergeron,[...]. N Engl J Med 2020
35
22

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Brian A Ference, Henry N Ginsberg, Ian Graham, Kausik K Ray, Chris J Packard, Eric Bruckert, Robert A Hegele, Ronald M Krauss, Frederick J Raal, Heribert Schunkert,[...]. Eur Heart J 2017
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.